Payden Equity Income Fund Adviser Class
PYVAX
NASDAQ
| Weiss Ratings | PYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C | |||
| Risk Index | Good | |||
| Risk Grade | B- | |||
| Company Info | PYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Paydenfunds | |||
| Manager/Tenure (Years) | James T. Wong (17), Alfred Giles (6), Michael Huynh (6), 1 other | |||
| Website | http://www.payden.com | |||
| Fund Information | PYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Payden Equity Income Fund Adviser Class | |||
| Category | Large Value | |||
| Sub-Category | US Equity Large Cap Value | |||
| Prospectus Objective | Equity-Income | |||
| Inception Date | Dec 01, 2011 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 5,000.00 | |||
| Minimum Subsequent Investment | 250.00 | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | PYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.93% | |||
| Dividend | PYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 1.88% | |||
| Asset Allocation | PYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 5.32% | |||
| Stock | 92.47% | |||
| U.S. Stock | 87.68% | |||
| Non-U.S. Stock | 4.79% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 2.22% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | PYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.15% | |||
| 30-Day Total Return | 0.84% | |||
| 60-Day Total Return | -0.58% | |||
| 90-Day Total Return | -0.79% | |||
| Year to Date Total Return | 13.21% | |||
| 1-Year Total Return | 15.54% | |||
| 2-Year Total Return | 26.18% | |||
| 3-Year Total Return | 59.04% | |||
| 5-Year Total Return | 45.21% | |||
| Price | PYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | PYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $18.99 | |||
| 1-Month Low NAV | $18.81 | |||
| 1-Month High NAV | $19.12 | |||
| 52-Week Low NAV | $16.61 | |||
| 52-Week Low NAV (Date) | Mar 30, 2026 | |||
| 52-Week High NAV | $19.36 | |||
| 52-Week High Price (Date) | Aug 14, 2026 | |||
| Beta / Standard Deviation | PYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.77 | |||
| Standard Deviation | 10.85 | |||
| Balance Sheet | PYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 1.09B | |||
| Operating Ratios | PYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.01% | |||
| Turnover Ratio | 112.00% | |||
| Performance | PYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 20.94% | |||
| Last Bear Market Total Return | -10.15% | |||